U.S. Markets closed
  • S&P 500

    3,768.25
    -27.29 (-0.72%)
     
  • Dow 30

    30,814.26
    -177.24 (-0.57%)
     
  • Nasdaq

    12,998.50
    -114.10 (-0.87%)
     
  • Russell 2000

    2,123.20
    -32.15 (-1.49%)
     
  • Crude Oil

    52.09
    -0.27 (-0.52%)
     
  • Gold

    1,836.80
    +6.90 (+0.38%)
     
  • Silver

    25.01
    +0.14 (+0.58%)
     
  • EUR/USD

    1.2082
    -0.0003 (-0.0242%)
     
  • 10-Yr Bond

    1.0970
    -0.0320 (-2.83%)
     
  • Vix

    24.34
    +1.09 (+4.69%)
     
  • GBP/USD

    1.3588
    +0.0004 (+0.0299%)
     
  • USD/JPY

    103.6860
    -0.1140 (-0.1098%)
     
  • BTC-USD

    36,183.46
    +444.70 (+1.24%)
     
  • CMC Crypto 200

    703.76
    -31.38 (-4.27%)
     
  • FTSE 100

    6,720.65
    -15.06 (-0.22%)
     
  • Nikkei 225

    28,242.21
    -276.97 (-0.97%)
     

US STOCKS-Vaccine optimism propels Nasdaq to record high

Noel Randewich
·3 min read

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)

* Boeing jumps on Ryanair's 737 MAX jet orders

* Jobless claims fall after rising for two straight weeks

* Goldman Sachs raises Tesla to "buy"

* Indexes: Dow +0.42%, S&P 500 +0.04%, Nasdaq +0.36% (Updates with afternoon trade)

By Noel Randewich

Dec 3 (Reuters) - The Nasdaq Composite hit an all-time high on Thursday as investors stayed focused on a COVID-19 vaccine and looked beyond bleak economic data, while Boeing Co lifted the Dow Jones Industrial Average.

The S&P 500 bounced between a slight loss and a slight gain after hitting a record high.

Boeing jumped over 7% after budget airline Ryanair ordered 75 additional 737 MAX jets with a list price of $9 billion, throwing a commercial lifeline to the embattled U.S. planemaker.

Tesla Inc surged 5% and drove the Nasdaq higher after Goldman Sachs upgraded the stock to "buy" in the run-up to the electric car maker's addition to the S&P 500.

Data showed the number of Americans filing first-time claims for jobless benefits fell last week, but remained extraordinarily high at 712,000, while a separate survey showed U.S. services industry activity slowed to a six-month low in November.

"I don't think we will see those numbers start to get back to normal until we start to see a rollout of a vaccine," said Sal Bruno, chief investment officer at IndexIQ. "The market is discounting that and saying we are looking forward to the first or second quarter and a rollout of the vaccine to the general population."

U.S. Senate Majority Leader Mitch McConnell cited some positive movement in congressional efforts to reach a compromise on a new coronavirus aid bill but gave no hints on when such a deal could be struck.

Progress in developing a working COVID-19 vaccine before the end of the year has driven the Wall Street's main indexes to record levels in recent days. Despite the economic destruction caused by the pandemic, the S&P 500 has gained 14% in 2020.

The Dow Jones Industrial Average was up 0.42% at 30,008.19 points, while the S&P 500 gained 0.04% to 3,670.36.

The Nasdaq Composite added 0.36% to 12,394.21.

Five of the 11 major S&P 500 sector indexes rose, energy up 2% and leading gains.

Ongoing vaccine optimism helped lift the S&P 1500 airlines index 6%. Cruise operators Carnival Corp jumped 10% and Norwegian Cruise Line Holdings Ltd surged 9%.

Cloud-security provider Zscaler Inc surged 23% after it reported better-than-expected first-quarter revenue and adjusted profit.

Waddell & Reed Financial surged 50%, extending gains from the previous session, after Australia's Macquarie Group announced a deal to buy the wealth manager for $1.7 billion.

Advancing issues outnumbered decliners on the NYSE by a 2.59-to-1 ratio; on Nasdaq, a 1.95-to-1 ratio favored advancers.

The S&P 500 posted 32 new 52-week highs and no new lows; the Nasdaq Composite recorded 154 new highs and six new lows. (Additional reporting by Shriya Ramakrishnan and Medha Singh in Bengaluru; Editing by Richard Chang)